Navigation Links
Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10
Date:11/20/2009

Researchers are invited to contribute their abstracts to the World Congress on Osteoporosis 2010 (IOF WCO ECCEO10), the largest global meeting devoted to all aspects of osteoporosis and osteoarthritis research and patient care. The Congress will be held in Florence, Italy from May 5-8, 2010.

Beginning today, abstracts can be submitted online at http://www.iofwco-ecceo10.org

The submission deadline is February 4, 2010.

IOF and ESCEO are pleased to announce that seven special sessions and mini-symposia will enhance the extensive scientific programme that includes 12 Plenary and 20 Meet-the-Expert sessions:

VPHOP Symposium: Assessing Fracture Risk: The Future for Designing New Therapies
Chairs: R. Rizzoli, M. Viceconti

  • The Role of Technology in the Fight Against Osteoporosis - R. Rizzoli (CH)
  • Clinical Prospectives on Osteoporosis: Bone and Muscle - D. Felsenberg (DE)
  • New Technologies to Predict the Risk of Fracture - F. Taddei (IT)
  • Cell and Tissue Based Simulation of Osteoporosis and Pharmacological Treatment - R. Mller (CH)
  • Tissue-level Imaging for Critical Risk Assessment - B. van Rietbergen (NL)
  • Personalised, Predictive, and Integrative Medicine: Future Scenarios for Osteoporosis - M. Viceconti (IT)

Minisymposium - Growth and Development of the Skeleton
Chairs: R. Lorenc, R. Rizzoli

  • Fetal and Neonatal Determinants of Bone Mineral Accumulation - C. Cooper (UK)
  • Novel Findings in Bone Development - E. Seeman (AU)
  • Celiac Disease and Bone Mass Accumulation Impairment - M.L. Bianchi (IT)

ESCEO Session: Dermatological Side Effects of Antiosteoporosis Medications
Chairs: D. Felsenberg, R. Rizzoli

  • Introduction - J.Y. Reginster (BE)
  • Various aspects of drug-related dermatological lesions - P. Musette (FR)
  • Cutaneous side effects of antiosteoporosis treatments - P. Musette (FR) <
    '/>"/>

Contact: N. Akhmisse
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. BIO-key(R) Provides Update to Special Shareholder Meeting
2. Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making
3. Reviews of microbial gene language published in special issue of Trends in Microbiology
4. Women with endometriosis need special care during pregnancy to avoid risk of premature birth
5. Continuous glucose monitoring technology -- special issue of Diabetes Technology and Therapeutics
6. GSA special paper presents new studies of Western US earth motion
7. Pest management specialist Charles Summers wins prestigious Woodworth Award
8. Explorations Group Announces Letter of Intent to Acquire Specialty Lighting Company
9. Explorations Group Announces Letter of Intent to Acquire Specialty Lighting Company
10. Special issue Comparative Cognition in Context now published
11. Special issue of BMC Microbiology spotlights standardized language for describing microbes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 20, 2014 C-Labs LLC, a leading provider ... Things (IoT), today announced the appointment of John ... Previously a strategic advisor to the firm, Mr. Traynor ... Traynor is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)... 18, 2014   EyeLock Inc. , a ... MorphoTrust USA (Safran), a leading U.S. ... a strategic partnership to offer comprehensive biometric identity ... (MVA), airport screening and financial services markets. ... serves consumers through a nationwide network of 1,100 ...
(Date:11/7/2014)... Researchers led by Dr. Debra Auguste, associate professor, ... at The City College of New York, have ... treatment for one of the most aggressive forms ... (TNBCs) have a high mortality rate owing to ... effective therapeutic options. However, Professor Auguste,s team, discovered ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... Researchers have long known that humans lack a key enzyme ... even plants -- that reverses severe sun damage. For ... at the atomic level to repair sun-damaged DNA. The ... prevention. In the early online edition of the journal ...
... Eeva Karjalainen, of the Finnish Forest Research Institute, Metla, "feel ... not many of us know that there is also scientific ... and other natural, green settings can reduce stress, ... Forest visits may also strengthen our immune system by increasing ...
... (SACRAMENTO, Calif.) A shared decision-making process would assist ... challenging and controversial choices presented when infants are born ... are being considered for elective corrective surgery, a new ... instances in which infants are born with conditions that ...
Cached Biology News:Researchers discover how key enzyme repairs sun-damaged DNA 2Study recommends that parents, physicians share decisions in sex development disorder surgery 2Study recommends that parents, physicians share decisions in sex development disorder surgery 3Study recommends that parents, physicians share decisions in sex development disorder surgery 4
(Date:11/28/2014)... (PRWEB) November 28, 2014 The report ... for all the important sub-segments of the market, in ... It maps the growth rates and market sizes for ... poised to witness rapid growth. It also includes analysis ... These company profiles include the financial performances, product portfolios, ...
(Date:11/27/2014)... 2014 First articles published ... Elsevier , a world-leading provider of scientific, ... to announce the launch of a new journal: ... The launch of Extreme Mechanics Letters ... forefront of applied sciences such as micro and nanotechnologies, ...
(Date:11/26/2014)... The report on the Global Smart Sensor Market in ... revenue forecasts and market trends. It expects the market ... to 2018. At the projected rate, the market is ... 2018. , Browse through the Global Smart Sensor Market ... market segmentation and in-depth analysis supported by a list ...
(Date:11/26/2014)... 2014 The announced sales of three healthcare ... looking to expand in non-healthcare areas, says Kalorama Information. ... research firm says that  Siemens is the third largest ... of the IVD market , with 5.5 billion in ... composition would likely affect IVD market shares.  ...
Breaking Biology Technology:Glycomics Market by Application, Product & End-Users is estimated to reach $928.11 Million by 2019 - New Research Report by MarketsandMarkets 2Glycomics Market by Application, Product & End-Users is estimated to reach $928.11 Million by 2019 - New Research Report by MarketsandMarkets 3Glycomics Market by Application, Product & End-Users is estimated to reach $928.11 Million by 2019 - New Research Report by MarketsandMarkets 4Glycomics Market by Application, Product & End-Users is estimated to reach $928.11 Million by 2019 - New Research Report by MarketsandMarkets 5Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 2Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 3Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 2Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 3Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 4Kalorama: Sale of Three Siemens Healthcare Units Raises Questions About Firm's IVD Future 2
... Inc. today announced that data from its phase 1/2 ... be highlighted in an oral presentation at the 50th ... in San Francisco, California, on December 9, 2008. , ... of the XIAP Antisense Oligonucleotide (AEG35156) in Combination with ...
... BioMarin Pharmaceutical,Inc. (Nasdaq: BMRN ) today announced that ... update at the Piper,Jaffray Healthcare Conference in New York City ... Interested parties may access a ... of the BioMarin website, http://www.BMRN.com . A,replay of the ...
... JOLLA, Calif., Nov. 25 TorreyPines Therapeutics, Inc.,(Nasdaq: ... from Eli Lilly & Company,a reduction in certain royalty ... sales of TorreyPines, clinical-stage compounds NGX426 and tezampanel,should either ... rate will be reduced three percentage points and the ...
Cached Biology Technology:Aegera Therapeutics' phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting 2Aegera Therapeutics' phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting 3BioMarin to Present at the Piper Jaffray Healthcare Conference 2TorreyPines Therapeutics Enters into Agreement to Reduce Royalty Rates and Delay Clinical Milestone Payments Due to Eli Lilly for NGX426 and Tezampanel 2
Edited by D. Rickwood, T.C. Ford and J.T. Steensgaard (1994) Compiles core data required by researchers carrying out any centrifugal separation, whether working with cells, organelles or macromolec...
Rat neural stem cell kits are intended for the in vitro growth and commitment to neuronal and glial lineage differentiation, of cultured fetal rat neural stem and progenitor cells expanded using FGF-...
Antibodies were affinity purified using epitopes specific to JLP immobilized on solid support....
... Price (1996) • This issue ... chemistry and the purification and ... on the following procedures is ... amino acid analysis and the ...
Biology Products: